“Massive Update for Joby Aviation Stock Investors”
$JOBYBullish
JOBY is a buy for high-risk investors; valuation is at historic lows (29x forward P/S) despite business progress and revenue-doubling acquisition.
On August 11th, Joby Aviation made an acquisition of Resident Sciences that could roughly double the company's revenue.
I've had a chance to evaluate that acquisition, the impact it could have on the company's cash flow, and evaluate the business, considering this acquisition and the progress the company has made overall to determine if this is a buying opportunity for investors with a very high risk tolerance.